BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19562681)

  • 1. Expression and regulation of the bile acid transporter, OSTalpha-OSTbeta in rat and human intestine and liver.
    Khan AA; Chow EC; Porte RJ; Pang KS; Groothuis GM
    Biopharm Drug Dispos; 2009 Jul; 30(5):241-58. PubMed ID: 19562681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver.
    Khan AA; Chow EC; van Loenen-Weemaes AM; Porte RJ; Pang KS; Groothuis GM
    Eur J Pharm Sci; 2009 May; 37(2):115-25. PubMed ID: 19429418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices.
    Khan AA; Chow EC; Porte RJ; Pang KS; Groothuis GM
    Toxicol In Vitro; 2011 Feb; 25(1):80-90. PubMed ID: 20888898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of VDR expression in rat and human intestine and liver--consequences for CYP3A expression.
    Khan AA; Dragt BS; Porte RJ; Groothuis GM
    Toxicol In Vitro; 2010 Apr; 24(3):822-9. PubMed ID: 20006981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.
    Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
    Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids.
    Frankenberg T; Rao A; Chen F; Haywood J; Shneider BL; Dawson PA
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G912-22. PubMed ID: 16357058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha,25-Dihydroxyvitamin D(3) triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver in vivo.
    Chow EC; Maeng HJ; Liu S; Khan AA; Groothuis GM; Pang KS
    Biopharm Drug Dispos; 2009 Nov; 30(8):457-75. PubMed ID: 19753549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes.
    Schaffner CA; Mwinyi J; Gai Z; Thasler WE; Eloranta JJ; Kullak-Ublick GA
    Liver Int; 2015 Apr; 35(4):1152-61. PubMed ID: 24703425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic functions of the organic solute transporter Ostα-Ostβ.
    Ballatori N
    Dig Dis; 2011; 29(1):13-7. PubMed ID: 21691099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species.
    Krasowski MD; Ai N; Hagey LR; Kollitz EM; Kullman SW; Reschly EJ; Ekins S
    BMC Biochem; 2011 Feb; 12():5. PubMed ID: 21291553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Farnesoid X Receptor Activation by Pharmacologic Inhibition of the Organic Solute Transporter α-β.
    van de Wiel SMW; de Waart DR; Oude Elferink RPJ; van de Graaf SFJ
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):223-237. PubMed ID: 29675448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine.
    Lee H; Zhang Y; Lee FY; Nelson SF; Gonzalez FJ; Edwards PA
    J Lipid Res; 2006 Jan; 47(1):201-14. PubMed ID: 16251721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced ileal expression of OSTalpha-OSTbeta in non-obese gallstone disease.
    Renner O; Harsch S; Strohmeyer A; Schimmel S; Stange EF
    J Lipid Res; 2008 Sep; 49(9):2045-54. PubMed ID: 18469300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter.
    Dawson PA; Hubbert M; Haywood J; Craddock AL; Zerangue N; Christian WV; Ballatori N
    J Biol Chem; 2005 Feb; 280(8):6960-8. PubMed ID: 15563450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta.
    Seward DJ; Koh AS; Boyer JL; Ballatori N
    J Biol Chem; 2003 Jul; 278(30):27473-82. PubMed ID: 12719432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia.
    Ballatori N; Christian WV; Lee JY; Dawson PA; Soroka CJ; Boyer JL; Madejczyk MS; Li N
    Hepatology; 2005 Dec; 42(6):1270-9. PubMed ID: 16317684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis.
    van de Wiel SMW; Porteiro B; Belt SC; Vogels EWM; Bolt I; Vermeulen JLM; de Waart DR; Verheij J; Muncan V; Oude Elferink RPJ; van de Graaf SFJ
    JHEP Rep; 2022 May; 4(5):100463. PubMed ID: 35462858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofibrate and perfluorodecanoate both upregulate the expression of the pregnane X receptor but oppositely affect its ligand-dependent induction on cytochrome P450 3A23.
    Ma Y; Sachdeva K; Liu J; Song X; Li Y; Yang D; Deng R; Chichester CO; Yan B
    Biochem Pharmacol; 2005 May; 69(9):1363-71. PubMed ID: 15826607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR.
    Okuwaki M; Takada T; Iwayanagi Y; Koh S; Kariya Y; Fujii H; Suzuki H
    Pharm Res; 2007 Feb; 24(2):390-8. PubMed ID: 17177110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.